MCID: ANT011
MIFTS: 46

Antisocial Personality Disorder malady

Category: Mental diseases

Aliases & Classifications for Antisocial Personality Disorder

About this section

Aliases & Descriptions for Antisocial Personality Disorder:

Name: Antisocial Personality Disorder 11 13 48 37 66
Psychopathic Personality Disorder 11
Dissocial Personality Disorder 11
Psychopathic Personality 11
 
Sociopathic Personality 11
Psychopath.personality 11
Asocial Personality 11

Classifications:



External Ids:

Disease Ontology11 DOID:10939
ICD1028 F60.2
ICD9CM30 301.7
MeSH37 D000987
NCIt43 C88413

Summaries for Antisocial Personality Disorder

About this section
Disease Ontology:11 A personality disorder that involves a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood.

MalaCards based summary: Antisocial Personality Disorder, also known as psychopathic personality disorder, is related to heroin dependence and cocaine dependence. An important gene associated with Antisocial Personality Disorder is MAOA (Monoamine Oxidase A), and among its related pathways are Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics and Biogenic Amine Synthesis. Affiliated tissues include prefrontal cortex, cortex and brain, and related mouse phenotypes are taste/olfaction and muscle.

Wikipedia:69 Antisocial personality disorder (ASPD), also known as dissocial personality disorder (DPD) and... more...

Related Diseases for Antisocial Personality Disorder

About this section

Diseases related to Antisocial Personality Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 93)
idRelated DiseaseScoreTop Affiliating Genes
1heroin dependence30.3ANKK1, DRD2, SLC6A4
2cocaine dependence29.9COL25A1, DRD2, MAOA, SLC6A3
3schizophrenia28.0COMT, DRD2, MAOA, MAOB, SLC6A3, SLC6A4
4personality disorder11.2
5conduct disorder10.9
6rabies10.6MAOA, SLC6A4
7chagas disease10.6MAOA, SLC6A4
8substance abuse10.5
9nonencapsulated sclerosing carcinoma10.5MAOA, SLC6A4
10pyromania10.5MAOA, SLC6A4
11ring chromosome 14 syndrome10.5COMT, MAOA
12malignant peripheral nerve sheath tumor10.5MAOA, SLC6A4
13neurodegeneration with optic atrophy, childhood onset10.5COMT, SLC6A4
14dental fluorosis10.5SLC6A3, SLC6A4
15lymphadenitis10.4MAOA, SLC6A4
16alcohol dependence10.4
17erysipelas10.4COMT, DRD2
18glutathionuria10.3COMT, SLC6A3
19substance dependence10.3
20lipedematous scalp10.3COMT, DRD2
21anxiety disorder10.3
22mixed malaria10.3MAOA, SLC6A4
23irritant dermatitis10.3DRD2, SLC6A3
24measles10.3COMT, SLC6A3
25borderline personality disorder10.3
26meckel's diverticulum10.2COMT, MAOA, SLC6A4
27vogt-koyanagi-harada disease10.2COMT, MAOA, SLC6A4
28hypoglycemic coma10.2COMT, MAOA, SLC6A4
29hypertropia10.2COMT, DRD2
30pyoderma gangrenosum10.2COMT, MAOA, SLC6A4
31fechtner syndrome10.2COMT, MAOA, SLC6A4
32antisocial personality disorder10.2ANKK1, DRD2
33basal cell carcinoma10.1DRD2, SLC6A3, SLC6A4
34pervasive developmental disorder10.1COMT, SLC6A3, SLC6A4
35albinism, oculocutaneous, type v10.1DRD2, MAOA, SLC6A4
36splenic disease10.1DRD2, SLC6A3, SLC6A4
37simpson-golabi-behmel syndrome10.1DRD2, SLC6A3
38hallucinogen dependence10.1DRD2, SLC6A3, SLC6A4
39ulcerative colitis10.1COMT, DRD2, SLC6A4
40multiple personality disorder10.1MAOA, MAOB
41lymphosarcoma10.1COMT, DRD2, SLC6A4
42pleurisy10.1MAOA, MAOB
43attention deficit-hyperactivity disorder10.1
44bipolar disorder10.1
45sexual sadism10.1
46pathological gambling10.1
47somatization disorder10.1
48generalized anxiety disorder10.1
49dysautonomia10.0COMT, MAOB
50phaeohyphomycosis10.0COMT, SLC6A4

Comorbidity relations with Antisocial Personality Disorder via Phenotypic Disease Network (PDN):


Schizophreniform Disorder

Graphical network of the top 20 diseases related to Antisocial Personality Disorder:



Diseases related to antisocial personality disorder

Symptoms for Antisocial Personality Disorder

About this section

Drugs & Therapeutics for Antisocial Personality Disorder

About this section

Drugs for Antisocial Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NaratriptanPhase 414143388-64-1, 121679-13-84440
Synonyms:
121679-13-8
AC-5013
AC1L1I6A
Amerge, Naramig,Naratriptan
BIDD:GT0312
C07792
CHEBI:7478
CHEMBL1278
CID4440
Colatan
D08255
DB00952
InChI=1/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H
L000432
 
LS-83062
MolPort-005-932-823
N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
NCGC00181786-01
Naramig
Naramig (TN)
Naratriptan (INN)
Naratriptanum
S1488_Selleck
UNII-QX3KXL1ZA2
naratriptan
naratriptanum
2
SerotoninPhase 4351050-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
3
EthanolPhase 2, Phase 3197164-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
4arginineNutraceuticalPhase 2393
5
Dopamine367851-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
6
yohimbine25146-48-58969
Synonyms:
(+)-Yohimbin
(+)-Yohimbine
(+)-yohimbine
(16alpha,17alpha)-17-Hydroxy-yohimban-16-carboxylic acid methyl ester
(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester
(16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester
146-48-5
17-Hydroxy-yohimbane-16-carboxylic acid methyl ester
17-Hydroxyyohimban-16-carboxylic acid methyl ester
17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester
17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester
2-Hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester
4-25-00-01237 (Beilstein Handbook Reference)
65-19-0
AC1L1S1D
APHRODINE
Actibine
Aphrodine
Aphrodyne
Aphrosol
BCBcMAP01_000032
BPBio1_000472
BRD-K35586044-001-02-6
BRD-K35586044-003-03-0
BRN 0097276
BSPBio_000428
BSPBio_001236
Baron-X
Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.
Bio1_000455
Bio1_000944
Bio1_001433
Bio2_000458
Bio2_000938
C09256
CHEBI:10093
CHEMBL15245
CID8969
Corynine
D08685
DB01392
Dayto himbin
EINECS 205-672-0
HMS1362N17
HMS1792N17
HMS1990N17
HMS2089G19
I14-13374
IDI1_002213
 
InChI=1/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12?,15?,17?,18-,19+/m0/s
Johimbin
KBio2_000576
KBio2_003144
KBio2_005712
KBio3_001031
KBio3_001032
KBioGR_000576
KBioSS_000576
LS-162738
Lopac0_001210
MLS000728591
MLS001333983
MolPort-001-794-653
NCGC00025018-05
NCGC00025018-06
NCGC00025018-07
NSC19509
Prestwick0_000584
Prestwick1_000584
Prestwick2_000584
Prestwick3_000584
Quebrachin
Quebrachine
SMP1_000320
SMR000058527
SMR000470778
SPBio_002647
STOCK1N-51304
Thybine
UNII-2Y49VWD90Q
Yocon
Yohimar
Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester
Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI)
Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI)
Yohimbic acid methyl ester
Yohimbin
Yohimbine
Yohimbine (DCF)
Yohimbol-16alpha-carboxylic acid, methyl ester (6CI)
Yohimex
Yoman
Yovital
methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate
methyl 17alpha-hydroxyyohimban-16alpha-carboxylate
nchembio.188-comp13
nchembio705-2
trans-Quinolizidine yohimbine
7
Norepinephrine66451-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
8
Guanfacine5629110-47-23519
Synonyms:
29110-47-2
29110-48-3 (mono-hydrochloride)
AC1L1G4B
BPBio1_000415
BRD-K32830106-003-03-0
BSPBio_000377
C07037
C9H9Cl2N3O
CAS-29110-48-3
CHEMBL862
CID3519
D08031
DB01018
EINECS 249-442-8
Estulic
Estulic (TN)
G1043_SIGMA
GUANFACINE
Guanfacina
Guanfacina [INN-Spanish]
Guanfacine (INN)
Guanfacine Monohydrochloride
Guanfacine [INN:BAN]
Guanfacinum
 
Guanfacinum [INN-Latin]
Intuniv
L000286
L013430
LS-174236
Lon798
Lopac-G-1043
Lopac0_000519
MolPort-003-941-447
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide
NCGC00015469-01
NCGC00015469-02
NCGC00015469-06
NCGC00024950-01
NCGC00024950-02
NCGC00024950-03
Prestwick0_000339
Prestwick1_000339
Prestwick2_000339
Prestwick3_000339
SPBio_002298
SPD 503
Tocris-1030
UNII-30OMY4G3MK
ZINC03872738

Interventional clinical trials:

(show all 25)
idNameStatusNCT IDPhase
1Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)CompletedNCT00000388Phase 4
2Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment OrderTerminatedNCT00282165Phase 4
3Effect of Omega-3 Supplementation on Child Behavior ProblemsCompletedNCT02016079Phase 2, Phase 3
4Personality-targeted Interventions for Adolescent Alcohol MisuseCompletedNCT00344474Phase 2, Phase 3
5The Impact of Psychopathic Traits on the Efficacy of a Substance Use InterventionRecruitingNCT01532934Phase 2
6Justice-Involved Veterans and Moral Reconation TherapyRecruitingNCT02524171Phase 2
7Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.RecruitingNCT02068261Phase 2
8Vasopressin Effects on Human Social CommunicationRecruitingNCT01327027Phase 2
9Conduct Disorder in Prison: Search for Prospective and Retrospective Recurring and Contextual ElementsCompletedNCT02493088
10Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing InmatesCompletedNCT01428349
11Impaired Decision-making in AdolescentsCompletedNCT01253993Phase 0
12Psychological Mechanisms of Behavioral DysregulationCompletedNCT00352456
13The Role of Norepinephrine in Emotional ProcessingCompletedNCT00109642
14Early Exposure to Lead and Adult Antisocial OutcomesCompletedNCT00285610
15To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II DisorderCompletedNCT01263548
16The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive BehaviorCompletedNCT02427672
17Study of Children at Risk for Disruptive Behavior DisordersCompletedNCT00001233
18Antisocial Behavior: Passing From Parent to Child to GrandchildRecruitingNCT00060788
19The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive BehaviorRecruitingNCT02674516
20ADHD: Gaps Between Patients With Alcohol-dependence and Impact on RelapseRecruitingNCT02364817
21Multisite Prevention of Conduct Problems (Fast Track)Active, not recruitingNCT01653535
22Mental Health Related to School Dropout in LuxembourgEnrolling by invitationNCT01354236
23Psychobiological Effects of Meditation on Offenders With PsychopathyNot yet recruitingNCT02894203
24Multisystemic Therapy-Emerging Adults TrialNot yet recruitingNCT02922335
25Role of Oxytocin in Telling and Detecting LiesWithdrawnNCT02361177Phase 0

Search NIH Clinical Center for Antisocial Personality Disorder


Cochrane evidence based reviews: antisocial personality disorder

Genetic Tests for Antisocial Personality Disorder

About this section

Anatomical Context for Antisocial Personality Disorder

About this section

MalaCards organs/tissues related to Antisocial Personality Disorder:

34
Prefrontal cortex, Cortex, Brain, Testes, Eye

Animal Models for Antisocial Personality Disorder or affiliated genes

About this section

MGI Mouse Phenotypes related to Antisocial Personality Disorder:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053949.5DRD2, SLC6A3, SNAP25
2MP:00053698.6COL25A1, DRD2, SLC6A3, SLC6A4, SNAP25
3MP:00053797.6ALDH2, COMT, DRD2, SLC6A3, SLC6A4, SNAP25
4MP:00036316.2ALDH2, COL25A1, COMT, DRD2, MAOA, MAOB
5MP:00053766.2ALDH2, COL25A1, COMT, DRD2, MAOA, MAOB
6MP:00053865.9ALDH2, COL25A1, COMT, DRD2, MAOA, MAOB

Publications for Antisocial Personality Disorder

About this section

Articles related to Antisocial Personality Disorder:

(show top 50)    (show all 360)
idTitleAuthorsYear
1
The Natural History of Antisocial Personality Disorder. (26175389)
2015
2
Physiological correlates of psychopathy, antisocial personality disorder, habitual aggression, and violence. (25129139)
2014
3
DSM-5 Antisocial Personality Disorder: Predictive Validity in a Prison Sample. (25180763)
2014
4
Antisocial Personality Disorder Subscale (Chinese Version) of the Structured Clinical Interview for the DSM-IV Axis II disorders: validation study in Cantonese-speaking Hong Kong Chinese. (23807628)
2013
5
The role of fearless dominance in differentiating psychopathy from antisocial personality disorder: comment on Marcus, Fulton, and Edens. (23339316)
2013
6
The social-cognitive basis of borderline and antisocial personality disorder: introduction. (23342953)
2013
7
The relationship between adult reactive and proactive aggression, hostile interpretation bias, and antisocial personality disorder. (23342957)
2013
8
Criminal behavior and cognitive processing in male offenders with antisocial personality disorder with and without comorbid psychopathy. (24378159)
2013
9
The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects. (22138326)
2012
10
Borderline but not antisocial personality disorder symptoms are related to self-reported partner aggression in late middle-age. (22732005)
2012
11
Electroencephalographic abnormalities in antisocial personality disorder. (22152445)
2012
12
The relationship of antisocial personality disorder and history of conduct disorder with crime incidence in schizophrenia. (23626636)
2012
13
Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder. (21554924)
2011
14
Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy. (21756448)
2011
15
Antisocial personality disorder is on a continuum with psychopathy. (20579518)
2010
16
Diagnosis and subtypes of adolescent antisocial personality disorder. (20420477)
2010
17
Borderline Personality Disorder, Bulimia Nervosa, Antisocial Personality Disorder, ADHD, Substance Use: Common Threads, Common Treatment Needs, and the Nature of Impulsivity. (21253443)
2010
18
Neurodevelopmental marker for limbic maldevelopment in antisocial personality disorder and psychopathy. (20807962)
2010
19
A treatment guideline for people with antisocial personality disorder: overcoming attitudinal barriers and evidential limitations. (19343700)
2009
20
Qualitative and quantitative EEG abnormalities in violent offenders with antisocial personality disorder. (19134998)
2009
21
The relationship between distress tolerance and antisocial personality disorder among male inner-city treatment seeking substance users. (18834298)
2008
22
Correspondence between self-report and interview-based assessments of antisocial personality disorder. (18315398)
2008
23
Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. (17592478)
2008
24
Serotonergic function in children with attention-deficit hyperactivity disorder: relationship to later antisocial personality disorder. (17470955)
2007
25
Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders. (16574783)
2006
26
Association between violent behaviour and impaired prepulse inhibition of the startle response in antisocial personality disorder and schizophrenia. (15680203)
2005
27
Mate similarity for substance dependence and antisocial personality disorder symptoms among parents of patients and controls. (15276222)
2004
28
Effect of patient sex, clinician sex, and sex role on the diagnosis of Antisocial Personality Disorder: models of underpathologizing and overpathologizing biases. (15141394)
2004
29
Neither antisocial personality disorder nor antisocial alcoholism is associated with the MAO-A gene in Han Chinese males. (12824808)
2003
30
Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects. (12745412)
2003
31
Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine. (14526596)
2003
32
Screening for antisocial personality disorder in drug users--a qualitative exploratory study on feasibility. (12953142)
2003
33
Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. (12167556)
2002
34
Evidence in an international sample of alcohol-dependent subjects of subgroups with specific symptom patterns of antisocial personality disorder. (12170119)
2002
35
Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone. (11285097)
2001
36
Suicidal behavior as essential diagnostic feature of antisocial personality disorder. (11799325)
2001
37
Therapeutic community treatment for substance abusers with antisocial personality disorder. (10435260)
1999
38
Antisocial Personality Disorder and depression in relation to alcoholism: a community-based sample. (9500310)
1998
39
Antisocial personality disorder, psychopathy and injecting heroin use. (9788008)
1998
40
Gender and drug differences in antisocial personality disorder. (9169384)
1997
41
An ethical framework for understanding patients with antisocial personality disorder who develop dementia: diagnosing and managing disorders of autonomy. (11656997)
1997
42
CSF 5-HIAA and family history of antisocial personality disorder in newborns. (9396964)
1997
43
Death rates in 71 men with antisocial personality disorder. A comparison with general population mortality. (8742541)
1996
44
A 16- to 45-year follow-up of 71 men with antisocial personality disorder. (7758299)
1995
45
Drinking outcomes of alcohol abusers diagnosed as antisocial personality disorder. (7978086)
1994
46
Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. (8033764)
1994
47
Antisocial personality disorder in abused and neglected children grown up. (8166307)
1994
48
Frontal P300 decrements in antisocial personality disorder. (7695021)
1994
49
An investigation into the internal structure of DSM-III antisocial personality disorder. (8488218)
1993
50
The antisocial personality disorder diagnosis. (2386266)
1990

Variations for Antisocial Personality Disorder

About this section

Expression for genes affiliated with Antisocial Personality Disorder

About this section
Search GEO for disease gene expression data for Antisocial Personality Disorder.

Pathways for genes affiliated with Antisocial Personality Disorder

About this section

Pathways related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

(show all 20)
idSuper pathwaysScoreTop Affiliating Genes
19.9MAOA, SLC6A4
2
Show member pathways
9.6COMT, MAOA
3
Show member pathways
9.5COMT, SLC6A4
4
Show member pathways
9.4MAOA, MAOB
5
Show member pathways
9.3MAOA, SLC6A3, SLC6A4
69.3MAOA, SLC6A4, SNAP25
7
Show member pathways
9.1ALDH2, COMT, MAOA
89.1MAOB, SLC6A3
9
Show member pathways
8.9ALDH2, MAOA, MAOB
10
Show member pathways
8.9ALDH2, MAOA, MAOB
118.9ALDH2, MAOA, MAOB
12
Show member pathways
8.9ALDH2, MAOA, MAOB
138.7COMT, MAOA, MAOB
14
Show member pathways
8.7COMT, MAOA, MAOB
15
Show member pathways
8.6ALDH2, COMT, MAOA, SLC6A3
16
Show member pathways
8.5DRD2, MAOA, MAOB, SLC6A3
17
Show member pathways
8.3ALDH2, COMT, MAOA, MAOB
18
Show member pathways
8.3ALDH2, COMT, MAOA, MAOB
19
Show member pathways
8.1ALDH2, COMT, MAOA, SLC6A3, SNAP25
20
Show member pathways
7.5COMT, DRD2, MAOA, MAOB, SLC6A3, SLC6A4

GO Terms for genes affiliated with Antisocial Personality Disorder

About this section

Cellular components related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axonGO:00304249.0COMT, DRD2, SLC6A3

Biological processes related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1monoamine transportGO:001584410.3SLC6A3, SLC6A4
2response to nicotineGO:003509410.0DRD2, SLC6A3
3response to iron ionGO:00100399.9DRD2, SLC6A3
4positive regulation of multicellular organism growthGO:00400189.9DRD2, SLC6A3
5adenohypophysis developmentGO:00219849.9DRD2, SLC6A3
6prepulse inhibitionGO:00601349.7DRD2, SLC6A3
7associative learningGO:00083069.6DRD2, SNAP25
8dopamine metabolic processGO:00424179.4COMT, DRD2
9response to cocaineGO:00422209.3DRD2, SLC6A3
10response to toxic substanceGO:00096369.3DRD2, MAOB, SLC6A4
11neurotransmitter catabolic processGO:00421359.2COMT, MAOA, MAOB
12locomotory behaviorGO:00076269.1DRD2, SLC6A3, SNAP25
13response to ethanolGO:00454718.9DRD2, MAOB, SLC6A3
14dopamine catabolic processGO:00424208.7COMT, MAOA, MAOB, SLC6A3
15response to drugGO:00424938.0COMT, DRD2, MAOB, SLC6A3, SLC6A4

Molecular functions related to Antisocial Personality Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1monoamine transmembrane transporter activityGO:00085049.9SLC6A3, SLC6A4
2syntaxin-1 bindingGO:00170759.7SLC6A4, SNAP25
3dopamine bindingGO:00352409.6DRD2, SLC6A3
4primary amine oxidase activityGO:00081319.6MAOA, MAOB

Sources for Antisocial Personality Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet